Research review
Lycopene with ashwagandha: what the research shows
Lycopene and ashwagandha are sometimes paired in supplement formulas, but they're studied for different things: ashwagandha mostly for stress and cortisol, lycopene mostly for oxidative-stress markers and, observationally, prostate health. No trial has tested them together or compared them.
The evidence doesn't support lycopene and ashwagandha as interchangeable, and it doesn't support them as a tested combination — no trial has given people both together. They're studied for different things entirely: ashwagandha's research is mostly about stress and cortisol, while lycopene's is mostly about oxidative-stress markers, cardiometabolic outcomes, and, in observational diet studies, prostate health.
What the evidence doesn't support
It doesn't support choosing one over the other for the same purpose, since their research doesn't cover the same purpose. It doesn't support either one as a treatment for a diagnosed condition — a stress disorder, high blood pressure, high cholesterol or prostate disease. And it doesn't support lycopene and ashwagandha as a tested pair: nothing published has given people both together and measured what happens, so any claimed combined effect is a formulation idea, not a finding.
What the trials found
Ashwagandha's evidence is the more developed of the two for a specific outcome. A 2024 meta-analysis pooling 9 randomized controlled trials in 558 people found ashwagandha significantly outperformed placebo on the Perceived Stress Scale, the Hamilton Anxiety Scale, and serum cortisol, though doses varied across the pooled trials rather than converging on one figure.
Lycopene's evidence looks different, and covers different ground. A 2023 GRADE-assessed meta-analysis of 34 randomized trials tested lycopene and tomato products against blood pressure, cholesterol, blood glucose, inflammation markers and body weight in adults, and found no significant effect on any of them — the only significant change was in malondialdehyde, a marker of oxidative stress. A smaller randomized trial of 80 adults with metabolic syndrome found 20 mg/day of encapsulated lycopene for 8 weeks reduced C-reactive protein and an oxidative-stress marker versus placebo, with no change in liver enzymes. Separately, a 2017 meta-analysis of 42 observational studies covering 692,012 people found higher dietary and blood lycopene levels associated with a modestly decreased prostate cancer risk — that's diet and blood-level data, not a tested supplement effect, and it says nothing about stress, cortisol or any outcome ashwagandha is studied for.
No trial has tested lycopene and ashwagandha combined, or measured whether one works better than the other for anything. They simply haven't been compared.
| Ingredient | Best evidence | Population | What it's actually studied for |
|---|---|---|---|
| Ashwagandha | Meta-analysis of 9 RCTs (558 people), significant effect on stress-scale scores and cortisol | Adults with chronic stress | Stress, cortisol, anxiety-scale scores |
| Lycopene | Meta-analysis of 34 RCTs, no effect on blood pressure, cholesterol, glucose or inflammation; effect on one oxidative-stress marker | Mixed adult populations across included trials | Cardiometabolic markers, oxidative stress, observational prostate-health associations |
Questions people ask
Is lycopene better than ashwagandha, or the other way around?
They're not answering the same question, so "better" doesn't really apply. Ashwagandha has a specific, more consistent evidence base for stress and cortisol; lycopene's evidence is spread across cardiometabolic markers and observational prostate-health data, with a generally more mixed or null result set. Comparing them head-to-head assumes they compete for the same effect, and the research doesn't support that assumption.
Can you take lycopene and ashwagandha together?
No trial has tested that combination. Each has its own separate safety profile — see who should not take lycopene — so mentioning both to a doctor or pharmacist, especially alongside any medication, is worth doing rather than assuming two different supplement categories are automatically fine stacked together.
Does ashwagandha do anything for oxidative stress the way lycopene does?
Ashwagandha's own trials are focused on stress-scale scores and cortisol, not oxidative-stress markers the way the lycopene trials above are. The two ingredients haven't been tested against the same oxidative-stress outcome, so there's no direct comparison to report.
When to talk to a doctor
Stress that interferes with daily life, sleep or work, or a cardiometabolic concern like elevated blood pressure or cholesterol, is worth raising with a doctor. Neither lycopene nor ashwagandha is a treatment for a diagnosed stress-related or cardiometabolic condition, and nothing in the research above supports using either as a substitute for evaluation or care a doctor might recommend. Ashwagandha should be discussed with a doctor if you're pregnant or nursing, have a thyroid condition, or take other medication; lycopene carries its own separate cautions — see who should not take lycopene.
Related reading: lycopene: what the research does and doesn't show, lycopene benefits: what the research does and doesn't show, and lycopene and medications.
Sources
- A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults In a 60-day trial, 600 mg/day of a concentrated ashwagandha extract lowered stress-scale scores and cortisol more than placebo in adults with chronic stress.
- Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis Pooling 9 trials in 558 people, ashwagandha lowered perceived stress, anxiety-scale scores and cortisol more than placebo.
- The Effects of Lycopene and Tomato Consumption on Cardiovascular Risk Factors in Adults: A Grade Assessment Systematic Review and Meta-analysis A meta-analysis of 34 randomized trials found lycopene and tomato products had no significant effect on blood pressure, cholesterol, blood sugar, inflammation or body weight; the only significant change was in an oxidative-stress marker.
- Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis A meta-analysis of 42 observational studies found higher dietary and blood lycopene levels associated with modestly lower prostate cancer risk, but found no significant link to advanced disease specifically — and observational diet data doesn't establish what a supplement would do.
- The Effects of Lycopene on Modulating Oxidative Stress and Liver Enzymes Levels in Metabolic Syndrome Patients: A Randomised Clinical Trial A randomized trial of 80 adults with metabolic syndrome found 20 mg/day of encapsulated lycopene for 8 weeks reduced CRP and an oxidative-stress marker versus placebo, with no change in liver enzymes.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.